co-presented by
ASSOCIATE SPONSORS
co-presented by
ASSOCIATE SPONSORS
Motilal Oswal recommended Neutral rating on Cipla with a target price of Rs 1310 in its research report dated January 24, 2026.
Jefferies downgraded Syngene to 'underperform' and slashed price target to Rs 480 from Rs 660; JPMorgan downgraded Cipla to "Neutral" with price target of Rs 1,460 after it reported disappointing Q3 results
Stocks to Watch, 8 January: Stocks like Tata Steel, NCL Industries, Infosys, Gland Pharma, Cipla, IRB Infrastructure Developers, Meesho, Adani Green Energy, Angel One, MOIL, and Midwest will be in focus on January 8.
Regulatory action at Pharmathen’s main manufacturing site in Greece could potentially disrupt supplies of one of Cipla’s important complex injectables
The market may remain range-bound, with support at the previous week’s low. Below are some short-term trading ideas to consider.
Stocks to Watch, 11 December: Stocks like Tata Steel, Lloyds Metal and Energy, Ashoka Buildcon, Puravankara, Petronet LNG, Life Insurance Corporation of India, Prestige Estates Projects, Mazagon Dock Shipbuilders, Bank of Baroda, DCM Shriram, KEI Industries, Cipla, State Bank of India, SBI Life Insurance Company, and Luxury Time will be in focus on December 11.
Deven Choksey recommended accumulate rating on Cipla with a target price of Rs 1,620 in its research report dated November 04, 2025.
Growth in the US business slowed in recent quarters
Prabhudas Lilladher recommended accumulate rating on Cipla with a target price of Rs 1675 in its research report dated October 31, 2025.
Choice Equity Broking recommended reduce rating on Cipla with a target price of Rs 1580 in its research report dated October 31, 2025.
Vohra was the second executive roped in from outside Cipla’s promoter family to lead the drug maker. Under his watch, Cipla saw a sharp improvement in profitability, driven by strategic expansion in chronic therapies, operational efficiencies and global partnerships.
This planned transition is in line with our succession process developed by the Board and Umang Vohra, says Cipla
Cipla share price: Analysts say that while the deal is a positive for the stock, it has already been priced in and investors are now resorting to profit booking.
Deven Choksey recommended hold rating on Cipla with a target price of Rs 1570 in its research report dated September 08, 2025.
Mirae Asset Sharekhan is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 1754 in its research report dated September 02, 2025.
The market is likely to consolidate further until it decisively gets back above last Thursday's high. Below are some short-term trading ideas to consider.
Overall, the trend remains favourable for bulls, despite the likelihood of intermittent consolidation. Below are some short-term trading ideas to consider.
The US government has long sought to shift pharmaceutical manufacturing back to domestic soil, citing both economic and national security concerns.
ICICI Securities is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 1800 in its research report dated July 26, 2025.
Prabhudas Lilladher is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 1730 in its research report dated July 27, 2025.
The market may continue to consolidate with a negative bias in the upcoming sessions. Below are some short-term trading ideas to consider.
